Effect of the polymorphism of tumor necrosis factor-α-308 G/A gene promoter on the susceptibility to ulcerative colitis: A meta-analysis

Digestion

Volumn 78, Issue 1, 2008, Pages 44-51

  Lu, Zonghai ^a   Chen, Lei ^a   Li, Hui ^a   Zhao, Yanjun ^a   Lin, Lin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Susceptibility; Tumor necrosis factor; Ulcerative colitis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNICITY; GENOTYPE; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52649178371     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000158605     Document Type: Review

References (46)

1. Shen EH, Das KM: Current therapeutic recommendations: infliximab for ulcerative colitis. J Clin Gastroenterol 2004;38:741-745.
2. Hanauer SB: Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006;12:S3-S9.
3. Mathew CG, Lewis CM: Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 2004;13:161-168.
4. Bonen DK, Cho JH: The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521-536.
5. Reimund JM, Wittersheim C, Dumont S, et al: Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 1996;16:144-150.
6. Braegger CP, Nicholls S, Murch SH, et al: Tumour necrosis factor-α in stool as a marker of intestinal inflammation. Lancet 1992; 339: 89-91.
7. Murch SH, Lamkin VA, Savage MO, et al: Serum concentrations of tumour necrosis factor-α in childhood chronic inflammatory bowel disease. Gut 1991;32:913-917.
8. Wilson AG, di Giovine FS, Blakemore AI, et al: Single base polymorphism in the human tumour necrosis factor-α gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1992;1:353.
9. Louis E, Franchimont D, Piron A, et al: Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113:401-406.
10. Bouma G, Crusius JB, Oudkerk PM, et al: Secretion of tumour necrosis factor-α and lymphotoxin-α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996;43:456-463.
11. Cuccchiara S, Latiano A, Palmieri O, et al: Polymorphisms of tumor necrosis factor-α but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007; 44:171-179.
12. Santos P, Suarez A, Rivas L, et al: TNF-α and IL-10 gene polymorphisms in inflammatory bowel disease: association of -1082 AA low producer IL-10 genotype with steroid dependency. Am J Gastroenterol 2006;101:1039-1047.
13. Sykora J, Subrt I, Dedek P, et al: Cytokine tumor necrosis factor-α A promoter gene polymorphism at position-308 G → A and pediatric inflammatory bowel disease: implication in ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 2006,42:479-487.
14. Balding J, Livingstone W, Conroy J, et al: Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphism. Mediators Inflamm 2004;13:181-187.
15. Vatay A, Bene L, Kovacs A, et al: Relationship between the tumor necrosis-α polymorphism and the serum C-reaction protein levels in inflammatory bowel disease. Immunogenetics 2003;55:247-252.
16. Martin K, Radlmayr M, Borchers R, et al: Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 2002;66:121-126.
17. Bouma G, Xia B, Crusius B, et al: Distribution of four polymorphisms in the tumour necrosis factor genes in patients with inflammatory bowel disease. Clin Exp Immunol 1996;103:391-396.
18. Celik Y, Dagli U, Kilic Y, et al: Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand J Gastroenterol 2006;41:559-565.
19. Mittal D, Manchanda P, Bid H, et al: Analysis of polymorphisms of tumor necrosis factor-α and polymorphic xenobiotic-metabolizing enzymes in inflammatory bowel disease: study from Northern India. Gastroenterology 2006;10:1440-1746.
20. Cao Q, Zhu Q, Wu ML, et al: Genetic susceptibility to ulcerative colitis in the Chinese Han ethnic population: association with TNF polymorphism. Chin Med J 2006;119:1198-1203.
21. Song Y, Wu KC, Zhang L, et al: Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease. Chin J Dig Dis 2005;6:170-174.
22. Sashio H, Tamura K, Ito R, et al: Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002;53:1020-1027.
23. Kim T, Byeong G, Hyoung D, et al: Tumor necrosis factor-α and IL-10 gene polymorphisms in Korean patients with inflammatory bowel disease. Korean J Gastroenterol 2003;42:377-386.
24. Cantor M, Nickerson P, Bernstein C, et al: The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005;100:1134-1142.
25. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, et al: Polymorphisms in the promoter region of tumor necrosis factor-α and the HLA-DRB1 locus in Mexican Mestizo patients with ulcerative colitis. Immunol Lett 2004; 95: 31-35.
26. Bouma G, Crusius J, Gonzalez M, et al: Genetic markers in clinically well-defined patients with ulcerative colitis. Clin Exp Immunol 1999; 115: 294-300.
27. van Heel DA, Udalova IA, De Silva AP, et al: Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors. Hum Mol Genet 2002; 11:1281-1289.
28. Koss K, Satsangi J, Fanning GC, et al: Cytokine (TNF-α, LT-α and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 2000;1:185-190.
29. Hirv K, Seyfarth M, Uibo R, et al: Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: association with HLA-DR and -DQ alleles and subclinical markers. Scand J Gastroenterol 1999;34:1025-1032.
30. Louis E, Satsangi J, Roussomoustakaki M, et al: Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996;39:705-710.
31. Fidder H, Heijmans R, Chowers Y, et al: TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease. Int J Immunogenet 2006;33:81-85.
32. Tremelling M, Waller S, Bredin F, et al: Genetic variants in TNF-α but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort. Inflamm Bowel Dis 2006;12:178-184.
33. Hampe J, Shaw SH, Saiz R, et al: Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999;65:1647-1655.
34. Bayley JP, de Rooij H, van den Elsen PJ, et al: Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-α promoter. Cytokine 2001;14:316-323.
35. Uglialoro AM, Turbay D, Pesavento PA, et al: Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens 1998;52:359-367.
36. Baena A, Leung JY, Sullivan AD, et al: TNF-α promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun 2002;3:482-487.
37. Suchy J, Klujszo-Grabowska E, Kladny J, et al: Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer 2008;8:112.
38. Wilson AG, Symons JA, McDowell TL, et al: Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199.
39. Mayne ST, Buenconsejo J, Anderich DT: Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999;149:13-20.
40. Badawi AF, Mostafa MH, Probert A, et al: Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev 1995;4:45-59.
41. Williams MP, Pounder RE: Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 1999;94:S11-S16.
42. Rhodes JM, Campbell BJ: Inflammation and colorectal cancer: IBD associated and sporadic cancer compared. Trends Mol Med 2002;8:10-16.
43. Jackson JR, Seed MP, Kircher CH, et al: The codependence of angiogenesis and chronic inflammation. FASEB J 1997;11:457-465.
44. Phoa N, Epe B: Influence of nitric oxide on the generation and repair of oxidative DNA damage in mammalian cells. Carcinogenesis (Lond) 2002;23:469-475.
45. Nakajima N, Kuwayama H, Ito Y, et al: Helicobacter pylori , neutrophils, interleukins, and gastric epithelial proliferation. J Clin Gastroenterol 1997;25(suppl 1):S198-S202.
46. Eberhart CE, Coffey RJ, Radhika A, et al: Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188.